Cibus (CBUS) Non-Current Debt (2020 - 2026)
Cibus (CBUS) posted Non-Current Debt of $93000.0 for Q4 2025, down 19.83% sequentially from $116000.0 in Q3 2025, and down 58.85% YoY from $226000.0 in Q4 2024.
Cibus (CBUS) Non-Current Debt (2020 - 2026) Analysis & Trends
Cibus has reported Non-Current Debt for 5 years, with the latest figure at $93000.0 in Q4 2025.
- Quarterly Non-Current Debt fell 58.85% year-over-year to $93000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $93000.0 (down 58.85% YoY) and the FY2025 annual result came in at $93000.0, down 58.85% from the prior year.
- Non-Current Debt slipped to $93000.0 in Q4 2025 per CBUS's latest filing, from $116000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $2.3 million in Q2 2023 and troughed at $93000.0 in Q4 2025.
- A 4-year average of $568000.0 and a median of $328000.0 in 2024 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 53.74% in 2024, down 84.0% in 2024.
- Over 4 years, Non-Current Debt stood at $1.5 million in 2021, then sank by 64.69% to $536000.0 in 2023, then slumped by 57.84% to $226000.0 in 2024, then slumped by 58.85% to $93000.0 in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $93000.0, $116000.0, and $140000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 365,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 536,000.00 |
| Sep 30, 2023 | 629,000.00 |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 1.52 Mn |
| Sep 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.52 Mn |